Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice

Figure 6 Capillary vascularity (mean ± SE) of 7 d, 14 d, and 21 d after vehicle (0. 1% DMSO), CUR or THC (300 and 3000 mg/kg BW) treatment in control and HepG2 groups. ^aP < 0.001, vs control group with vehicle; ^bP < 0.005, vs 14 d HepG2 group with vehicle; ^cP < 0.001, vs 14 d HepG2 group with vehicle; ^dP < 0.01, vs 14 d HepG2-THC 300 group; ^eP < 0.001, vs 21 d HepG2 group with vehicle; ^fP < 0.001, vs 21 d HepG2-THC 300 group; ^gP < 0.05, vs 21 d HepG2-CUR 3000 group.